|
US3239539A
(en)
*
|
1960-12-02 |
1966-03-08 |
Exxon Research Engineering Co |
Gem dimethylol alicyclic esters
|
|
GB1026401A
(en)
|
1961-02-23 |
1966-04-20 |
Wellcome Found |
Isatin thiosemicarbazones,their preparation and pharmaceutical formulations containing them
|
|
US3250791A
(en)
*
|
1961-12-29 |
1966-05-10 |
Du Pont |
Tetracyanoethylene oxide and process for preparing same
|
|
GB1231783A
(en)
|
1967-05-16 |
1971-05-12 |
May & Baker Ltd |
Benzene derivatives
|
|
DE1767924A1
(de)
*
|
1968-07-02 |
1971-10-07 |
Bayer Ag |
1-Phenyl-4,4-dialkyl-thiosemicarbazide
|
|
JPS5695161A
(en)
*
|
1979-12-28 |
1981-08-01 |
Otsuka Pharmaceut Factory Inc |
2-admantanon derivative
|
|
US4463077A
(en)
*
|
1982-05-26 |
1984-07-31 |
Toray Industries, Inc. |
Electrophotographic photosensitive material comprises pyrazoline and hydrazone derivatives
|
|
US4537844A
(en)
|
1982-10-08 |
1985-08-27 |
Ricoh Co. Ltd. |
Electrophotographic element containing disazo compound
|
|
FI833651A7
(fi)
*
|
1982-10-11 |
1984-04-12 |
Hoechst Ag |
3-aryl-7-klor-3,4-dihydro-akridin-1,9-(2h,1oh)-dion-1-oximer och -l-hydrazonderivat, deras salter,foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaending
|
|
DE3237649A1
(de)
|
1982-10-11 |
1984-04-12 |
Hoechst Ag, 6230 Frankfurt |
3-aryl-7-chlor-10-hydroxy-3,4-dihydro-acridin-1,9-(2h, 10h)-dion-1-oxime und -1-hydrazonderivate, deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
|
|
HU189765B
(en)
|
1983-10-25 |
1986-07-28 |
Richter Gedeon Vegyeszeti Gyar Rt,Hu |
Process for preparing n-substituted 1-(bis (hydroxy-metiol)-methyl)-isoquinoline-derivatives
|
|
US4619878A
(en)
|
1984-06-26 |
1986-10-28 |
Ricoh Co., Ltd. |
Tetrazonium salt compound, disazo compound, method for preparing the same, and photosensitive material containing said disazo compound for use in electrophotography
|
|
EP0183398B1
(en)
|
1984-11-30 |
1989-04-12 |
FISONS plc |
Angiotensin converting enzyme inhibitors and their production and use as pharmaceuticals
|
|
US4833153A
(en)
|
1985-11-08 |
1989-05-23 |
Glaxo Group Limited |
Indole derivatives
|
|
IL77496A
(en)
*
|
1986-01-01 |
1989-02-28 |
Univ Ramot |
Anti-viral preparations comprising isatine 3-thiosemicarbazones
|
|
AU7285487A
(en)
|
1986-04-07 |
1987-11-09 |
Upjohn Company, The |
Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions
|
|
US5023334A
(en)
|
1986-10-03 |
1991-06-11 |
The Upjohn Company |
Anthelmintic pyridinyl acylhydrazones
|
|
GB2210041B
(en)
|
1987-09-09 |
1992-07-01 |
Ici Plc |
Fungicidal derivatives of propenoic acid
|
|
US5155110A
(en)
|
1987-10-27 |
1992-10-13 |
Warner-Lambert Company |
Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
|
|
US4958010A
(en)
|
1988-02-16 |
1990-09-18 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside lactam derivatives
|
|
ZA894508B
(en)
|
1988-06-16 |
1990-03-28 |
Rohm & Haas |
Pharmaceutical compounds
|
|
JP2521137B2
(ja)
|
1988-11-08 |
1996-07-31 |
富士写真フイルム株式会社 |
電子写真感光体
|
|
US5196291A
(en)
*
|
1989-05-24 |
1993-03-23 |
Fuji Photo Film Co., Ltd. |
Silver halide photographic material
|
|
EP0420005B1
(en)
|
1989-09-18 |
1996-07-10 |
Fuji Photo Film Co., Ltd. |
High contrast silver halide photographic material
|
|
US5135928A
(en)
|
1989-10-25 |
1992-08-04 |
Egis Gyogyszergyar |
Triazolo derivatives and process for their preparation
|
|
US4985434A
(en)
|
1989-10-31 |
1991-01-15 |
Biocryst, Inc. |
7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same
|
|
US5008270A
(en)
|
1989-10-31 |
1991-04-16 |
Biocryst, Inc. |
2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
|
|
US4985433A
(en)
|
1989-10-31 |
1991-01-15 |
Biocryst, Inc. |
2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
|
|
US5008265A
(en)
|
1989-10-31 |
1991-04-16 |
Biocryst, Inc. |
2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
|
|
JP3093767B2
(ja)
|
1989-11-27 |
2000-10-03 |
松下電工株式会社 |
洗浄装置
|
|
US5189039A
(en)
|
1989-11-29 |
1993-02-23 |
Biocryst, Inc. |
7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same
|
|
US5230983A
(en)
|
1990-04-13 |
1993-07-27 |
Fuji Photo Film Co., Ltd. |
Silver halide photographic material
|
|
LU87766A1
(fr)
|
1990-07-20 |
1992-03-11 |
Oreal |
Utilisation de derives de pyrimidine 3-oxyde pour freiner la chute des cheveux et compositions topiques mises en oeuvre
|
|
NZ239846A
(en)
*
|
1990-09-27 |
1994-11-25 |
Merck & Co Inc |
Sulphonamide derivatives and pharmaceutical compositions thereof
|
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
JPH05333467A
(ja)
|
1991-05-02 |
1993-12-17 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
|
US5714493A
(en)
|
1991-05-10 |
1998-02-03 |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
USRE37650E1
(en)
|
1991-05-10 |
2002-04-09 |
Aventis Pharmacetical Products, Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
ES2108120T3
(es)
|
1991-05-10 |
1997-12-16 |
Rhone Poulenc Rorer Int |
Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf.
|
|
US5710158A
(en)
|
1991-05-10 |
1998-01-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5344836A
(en)
|
1991-11-11 |
1994-09-06 |
Ono Pharmaceutical Co., Ltd. |
Fused benzeneoxyacetic acid derivatives
|
|
DE4138820A1
(de)
|
1991-11-26 |
1993-05-27 |
Basf Ag |
Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
|
|
JP2787630B2
(ja)
|
1992-02-06 |
1998-08-20 |
富士写真フイルム株式会社 |
ハロゲン化銀感光材料
|
|
DE4207400A1
(de)
|
1992-03-09 |
1993-09-16 |
Bayer Ag |
Hydrazone
|
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
|
US5358946A
(en)
*
|
1992-05-29 |
1994-10-25 |
The Du Pont Merck Pharmaceutical Company |
Heterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosis
|
|
JP2994182B2
(ja)
|
1992-07-23 |
1999-12-27 |
石原産業株式会社 |
アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
|
|
EP0600832A1
(de)
|
1992-11-27 |
1994-06-08 |
Ciba-Geigy Ag |
Diaminobenzoe- und Diaminophthalsäurederivate und ihre Verfahren als Proteinkinase-Inhibitoren
|
|
TW251302B
(OSRAM)
*
|
1992-12-28 |
1995-07-11 |
Kao Corp |
|
|
US5618829A
(en)
|
1993-01-28 |
1997-04-08 |
Mitsubishi Chemical Corporation |
Tyrosine kinase inhibitors and benzoylacrylamide derivatives
|
|
US5750088A
(en)
|
1993-03-30 |
1998-05-12 |
The Dupont Merck Pharmaceutical Company |
Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
|
|
JP3350739B2
(ja)
|
1993-06-10 |
2002-11-25 |
コニカ株式会社 |
黒白ハロゲン化銀写真感光材料の現像処理方法
|
|
US5543520A
(en)
|
1993-10-01 |
1996-08-06 |
Ciba-Geigy Corporation |
Pyrimidine derivatives
|
|
AU693475B2
(en)
|
1993-10-01 |
1998-07-02 |
Novartis Ag |
Pyrimidineamine derivatives and processes for the preparation thereof
|
|
US5656643A
(en)
|
1993-11-08 |
1997-08-12 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
KR100225721B1
(ko)
|
1994-02-23 |
1999-10-15 |
디. 제이. 우드, 스피겔 알렌 제이 |
4-헤테로사이클릴-치환된 퀴나졸린 유도체, 이들의 제조 방법 및항암제로서의 용도
|
|
CN1105703C
(zh)
|
1994-04-06 |
2003-04-16 |
盐野义制药株式会社 |
α－取代苯乙酸衍生物,它的制备及含有该化合物的农用杀菌剂
|
|
EP0704215A3
(en)
*
|
1994-06-02 |
1998-04-01 |
Takeda Chemical Industries, Ltd. |
Inhibitor of vascular permeability enhancer
|
|
TW280906B
(OSRAM)
|
1994-12-01 |
1996-07-11 |
Ibm |
|
|
DE19501481A1
(de)
|
1995-01-19 |
1996-07-25 |
Bayer Ag |
2,8-Disubstituierte Chinazolinone
|
|
JPH08220666A
(ja)
|
1995-02-15 |
1996-08-30 |
Konica Corp |
黒白ハロゲン化銀写真感光材料及びその処理方法
|
|
WO1996033977A1
(en)
|
1995-04-27 |
1996-10-31 |
Zeneca Limited |
Quinazoline derivatives
|
|
WO1996040648A1
(en)
|
1995-06-07 |
1996-12-19 |
Sugen, Inc. |
Quinazolines and pharmaceutical compositions
|
|
US6265427B1
(en)
|
1995-06-07 |
2001-07-24 |
The Proctor & Gamble Company |
Pharmaceutical composition for the method of treating leukemia
|
|
US5763470A
(en)
|
1995-06-07 |
1998-06-09 |
Sugen Inc. |
Benzopyran compounds and methods for their use
|
|
US5633786A
(en)
|
1995-08-21 |
1997-05-27 |
Motorola |
Shield assembly and method of shielding suitable for use in a communication device
|
|
AR004010A1
(es)
|
1995-10-11 |
1998-09-30 |
Glaxo Group Ltd |
Compuestos heterociclicos
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DE19545878A1
(de)
|
1995-12-08 |
1997-06-12 |
Basf Ag |
Pyridylcarbamate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung
|
|
US5760041A
(en)
|
1996-02-05 |
1998-06-02 |
American Cyanamid Company |
4-aminoquinazoline EGFR Inhibitors
|
|
DE19619518A1
(de)
|
1996-05-15 |
1997-11-20 |
Haeussler & Sauter Kg |
Verfahren zur Anbringung eines Fadens an einem Aufgußbeutel
|
|
US6306574B1
(en)
|
1996-05-17 |
2001-10-23 |
Fuji Photo Film Co., Ltd. |
Photothermographic material
|
|
US20040171032A1
(en)
*
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Non-phosphorous-linked oligomeric compounds and their use in gene modulation
|
|
WO1998002437A1
(en)
|
1996-07-13 |
1998-01-22 |
Glaxo Group Limited |
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
|
|
HRP970371A2
(en)
|
1996-07-13 |
1998-08-31 |
Kathryn Jane Smith |
Heterocyclic compounds
|
|
EP0912559B1
(en)
|
1996-07-13 |
2002-11-06 |
Glaxo Group Limited |
Fused heterocyclic compounds as protein tyrosine kinase inhibitors
|
|
ES2297864T3
(es)
|
1996-08-23 |
2008-05-01 |
Novartis Ag |
Pirrolopirimidinas sustituidas y procesos para su preparacion.
|
|
AU720135B2
(en)
|
1996-10-02 |
2000-05-25 |
Novartis Ag |
Pyrimidine derivatives and processes for the preparation thereof
|
|
CO4940418A1
(es)
|
1997-07-18 |
2000-07-24 |
Novartis Ag |
Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
|
|
ZA986729B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitors of tyrosine kinases
|
|
ZA986732B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitiors of tyrosine kinases
|
|
GB9716557D0
(en)
|
1997-08-06 |
1997-10-08 |
Glaxo Group Ltd |
Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
|
|
EP0902028A1
(en)
|
1997-09-11 |
1999-03-17 |
E.I. Du Pont De Nemours And Company |
Tetrazoline herbicides
|
|
US6184377B1
(en)
|
1997-12-15 |
2001-02-06 |
Sepracor Inc. |
Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
|
|
WO1999031073A1
(en)
|
1997-12-15 |
1999-06-24 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel pyrimidine-5-carboxamide derivatives
|
|
EP1051383B1
(en)
|
1998-02-06 |
2004-07-28 |
De Montfort University |
Hydroxylation activated prodrugs
|
|
CA2330458A1
(en)
|
1998-04-29 |
1999-11-04 |
Georgetown University |
Methods of identifying and using hla binding compounds as hla-agonists and antagonists
|
|
US20010051628A1
(en)
|
1998-05-04 |
2001-12-13 |
H.-J. Su Huang |
Methods to modulate the resistance of cells to apoptosis mediated by mutant epidermal growth factor receptors
|
|
US6289352B1
(en)
|
1998-05-29 |
2001-09-11 |
Crystal Decisions, Inc. |
Apparatus and method for compound on-line analytical processing in databases
|
|
JPH11345811A
(ja)
|
1998-06-01 |
1999-12-14 |
Seiko Instruments Inc |
半導体装置の製造方法
|
|
US6596770B2
(en)
|
2000-05-05 |
2003-07-22 |
Medinox, Inc. |
Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
|
|
US20030181495A1
(en)
|
1998-06-23 |
2003-09-25 |
Medinox, Inc. |
Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
|
|
US6525072B1
(en)
|
1998-08-31 |
2003-02-25 |
Sugen, Inc. |
Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
|
|
JP2000143636A
(ja)
|
1998-09-02 |
2000-05-26 |
Sumitomo Pharmaceut Co Ltd |
アミノ誘導体
|
|
US20020010550A1
(en)
|
1998-09-14 |
2002-01-24 |
George M. Grass |
Pharmacokinetic-based drug design tool and method
|
|
US6420560B1
(en)
*
|
1999-06-07 |
2002-07-16 |
Theravance, Inc. |
H1—histamine receptor antagonists
|
|
US6538002B1
(en)
*
|
1999-06-11 |
2003-03-25 |
Merck & Co., Inc. |
Cyclopentyl modulators of chemokine receptor activity
|
|
SK3542002A3
(en)
|
1999-09-15 |
2003-04-01 |
Warner Lambert Co |
Pteridinones as kinase inhibitors
|
|
US7264932B2
(en)
|
1999-09-24 |
2007-09-04 |
Applera Corporation |
Nuclease inhibitor cocktail
|
|
GB9924862D0
(en)
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
JP2001172217A
(ja)
|
1999-12-21 |
2001-06-26 |
Shionogi & Co Ltd |
殺ダニ活性および殺菌活性を有するエチレン誘導体
|
|
GB2357971A
(en)
|
1999-12-23 |
2001-07-11 |
Novartis Ag |
Protection of plants against microorganism attack
|
|
ITMI992711A1
(it)
|
1999-12-27 |
2001-06-27 |
Novartis Ag |
Composti organici
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
BR0104424A
(pt)
|
2000-02-05 |
2002-01-08 |
Vertex Pharma |
Composições de pirazol úteis como inibidores de erk
|
|
US6420382B2
(en)
|
2000-02-25 |
2002-07-16 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6313138B1
(en)
|
2000-02-25 |
2001-11-06 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
JP2004500388A
(ja)
|
2000-03-01 |
2004-01-08 |
スローン−ケッタリング インスティトュート フォア キャンサー リサーチ |
エポチロン、その中間体およびその類似体の合成
|
|
GB0007657D0
(en)
|
2000-03-29 |
2000-05-17 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB2372562A
(en)
|
2000-04-26 |
2002-08-28 |
Ribotargets Ltd |
In silico screening
|
|
DE60141871D1
(de)
|
2000-05-05 |
2010-06-02 |
Wallac Oy |
Oligonukleotidmarkierungsstoffe und ihre Verwendung
|
|
DE10023492A1
(de)
|
2000-05-09 |
2001-11-22 |
Schering Ag |
Aza- und Polyazanthranylamide und deren Verwendung als Arzneimittel
|
|
US6489094B2
(en)
|
2000-05-31 |
2002-12-03 |
Pfizer Inc. |
Method and device for drug-drug interaction testing sample preparation
|
|
US7211192B2
(en)
|
2000-06-02 |
2007-05-01 |
The Regents Of The University Of California |
Hybrid organic-inorganic adsorbents
|
|
US7022484B2
(en)
|
2000-06-08 |
2006-04-04 |
Board Of Regents, The University Of Texas System |
Methods for treating neuropathological states and neurogenic inflammatory states and methods for identifying compounds useful therein
|
|
US20020013334A1
(en)
|
2000-06-15 |
2002-01-31 |
Robl Jeffrey A. |
HMG-CoA reductase inhibitors and method
|
|
US20020028826A1
(en)
|
2000-06-15 |
2002-03-07 |
Robl Jeffrey A. |
HMG-CoA reductase inhibitors and method
|
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
CA2414406A1
(en)
|
2000-06-26 |
2002-01-03 |
The Regents Of The University Of Michigan |
Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin
|
|
AU2001276934A1
(en)
|
2000-07-18 |
2002-02-05 |
Joslin Diabetes Center Inc. |
Methods of modulating fibrosis
|
|
US7067046B2
(en)
|
2000-08-04 |
2006-06-27 |
Essen Instruments, Inc. |
System for rapid chemical activation in high-throughput electrophysiological measurements
|
|
US6647342B2
(en)
|
2000-08-07 |
2003-11-11 |
Novodynamics, Inc. |
Knowledge-based process for the development of materials
|
|
GB0022438D0
(en)
|
2000-09-13 |
2000-11-01 |
Novartis Ag |
Organic Compounds
|
|
AU2002226877B2
(en)
|
2000-10-17 |
2006-01-12 |
Merck & Co., Inc. |
Orally active salts with tyrosine kinase activity
|
|
JP4366081B2
(ja)
|
2001-05-22 |
2009-11-18 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
高度に精製されたアンチエンドトキシン化合物
|
|
JP2002361158A
(ja)
|
2001-06-07 |
2002-12-17 |
Aica Kogyo Co Ltd |
塗布装置
|
|
US6352168B1
(en)
|
2001-06-21 |
2002-03-05 |
Jung-Chuang Lin |
Rotation cup
|
|
US20040235798A1
(en)
|
2001-07-05 |
2004-11-25 |
Murthi Krishna K |
Compositions and methods for inhibiting prenyltransferases
|
|
AU2002333233A1
(en)
|
2001-07-09 |
2003-01-29 |
Pharmacia Italia Spa |
Interaction inhibitors of tcf-4 with beta-catenin
|
|
US7071190B2
(en)
|
2002-02-15 |
2006-07-04 |
Rigel Pharmaceuticals, Inc. |
Inhibitors to tubulin polymerization
|
|
RU2004132719A
(ru)
*
|
2002-04-08 |
2005-08-27 |
Торрент Фармасьютикалз Лтд. (In) |
Тиазолидин-4-карбонитрилы и их аналоги, применение указанных соединений в качестве ингибиторов дипептидилпептидаз
|
|
US7202367B2
(en)
|
2002-05-31 |
2007-04-10 |
Rhodia Chimie |
Process for arylating or vinylating or alkynating a nucleophilic compound
|
|
US7355053B2
(en)
*
|
2002-10-18 |
2008-04-08 |
Basf Aktiengesellschaft |
1-phenylpyrrolidine-2-one-3-carboxamides
|
|
US20060252798A1
(en)
|
2003-02-05 |
2006-11-09 |
Richardson Desi R |
Metal ion chelators and therapeutic use thereof
|
|
US7052870B2
(en)
|
2003-02-18 |
2006-05-30 |
Whitehead Institute For Biomedical Research |
mTOR kinase-associated proteins
|
|
EP1614676A4
(en)
|
2003-03-27 |
2009-03-25 |
Kirin Pharma Kk |
CONNECTION TO INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICAMENT CONTAINING THEREOF
|
|
US20040193538A1
(en)
|
2003-03-31 |
2004-09-30 |
Raines Walter L. |
Receipt processing system and method
|
|
US7427683B2
(en)
*
|
2003-04-25 |
2008-09-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
c-fms kinase inhibitors
|
|
US20050010017A1
(en)
*
|
2003-07-11 |
2005-01-13 |
Blakely Dale Milton |
Addition of UV inhibitors to pet process for maximum yield
|
|
US20050249697A1
(en)
|
2003-09-24 |
2005-11-10 |
Uhrich Kathryn E |
Compositions and methods for the inhibition of bone growth and resorption
|
|
CA2553242A1
(en)
|
2004-01-20 |
2005-08-04 |
Merck & Co., Inc. |
2,6-disubstituted piperidines as modulators of chemokine receptor activity
|
|
EP1713822B1
(en)
|
2004-01-30 |
2010-03-17 |
Medivir AB |
Hcv ns-3 serine protease inhibitors
|
|
ZA200607582B
(en)
|
2004-03-05 |
2009-02-25 |
Univ California |
Anti-parasitic compounds and methods of their use
|
|
DE502005002697D1
(de)
|
2004-10-13 |
2008-03-13 |
Merck Patent Gmbh |
Als kinaseinhibitoren geeignete derivate des n,n'-diphenylharnstoffs
|
|
FR2879194B1
(fr)
|
2004-12-14 |
2007-01-19 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques modulateurs des recepteurs de type ppar, leur procede de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
JP2006181940A
(ja)
|
2004-12-28 |
2006-07-13 |
Mitsubishi Paper Mills Ltd |
インクジェット用記録材料
|
|
CN1891701A
(zh)
|
2005-07-07 |
2007-01-10 |
桑迪亚医药技术（上海）有限责任公司 |
杂芳环缩氨基硫脲类化合物及其衍生物和它们在制备抗肿瘤药物中的应用
|
|
CN100497309C
(zh)
|
2005-08-04 |
2009-06-10 |
卡南吉医药科技（上海）有限公司 |
杂芳环缩氨基硫脲类抗肿瘤药物的合成方法
|
|
KR20080090381A
(ko)
|
2005-08-29 |
2008-10-08 |
제라드 엠. 하우지 |
테라뮤틴 조절물질
|
|
EP1996193A2
(en)
|
2006-03-13 |
2008-12-03 |
OSI Pharmaceuticals, Inc. |
Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
|
|
JP2008008853A
(ja)
|
2006-06-30 |
2008-01-17 |
Univ Of Electro-Communications |
地点間距離変動検出装置及び方法
|
|
JP2008088107A
(ja)
|
2006-10-02 |
2008-04-17 |
Fujiyakuhin Co Ltd |
新規ピリダジン誘導体
|
|
US8034815B2
(en)
|
2007-01-11 |
2011-10-11 |
Critical Outcome Technologies, Inc. |
Compounds and method for treatment of cancer
|
|
CA2710039C
(en)
|
2007-12-26 |
2018-07-03 |
Critical Outcome Technologies, Inc. |
Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer
|
|
WO2010006438A1
(en)
|
2008-07-17 |
2010-01-21 |
Critical Outcome Technologies Inc. |
Thiosemicarbazone inhibitor compounds and cancer treatment methods
|